Hawk Kim

2.7k total citations
111 papers, 1.5k citations indexed

About

Hawk Kim is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Hawk Kim has authored 111 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 37 papers in Genetics and 29 papers in Oncology. Recurrent topics in Hawk Kim's work include Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Hawk Kim is often cited by papers focused on Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Hawk Kim collaborates with scholars based in South Korea, United States and Canada. Hawk Kim's co-authors include Jae‐Cheol Jo, Young Joo Min, Yunsuk Choi, Je‐Hwan Lee, Eui‐Kyu Noh, Jae-Hoo Park, Jin Ho Baek, Kyoo‐Hyung Lee, Young‐Don Joo and Jung‐Hee Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hawk Kim

107 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hawk Kim South Korea 22 882 443 342 340 256 111 1.5k
Yeo‐Kyeoung Kim South Korea 20 675 0.8× 261 0.6× 412 1.2× 253 0.7× 131 0.5× 91 1.2k
Yunsuk Choi South Korea 18 480 0.5× 444 1.0× 339 1.0× 178 0.5× 146 0.6× 101 1.1k
Hiroatsu Iida Japan 22 836 0.9× 405 0.9× 365 1.1× 205 0.6× 88 0.3× 83 1.4k
Paul Shaughnessy United States 20 1.3k 1.5× 508 1.1× 274 0.8× 269 0.8× 126 0.5× 85 1.8k
Karel Indrák Czechia 21 867 1.0× 224 0.5× 271 0.8× 765 2.3× 237 0.9× 147 1.6k
G. L. Phillips Canada 20 931 1.1× 507 1.1× 265 0.8× 325 1.0× 283 1.1× 47 1.6k
M. J. Barnett Canada 20 676 0.8× 388 0.9× 173 0.5× 243 0.7× 220 0.9× 43 1.3k
T. de Witte Netherlands 23 875 1.0× 394 0.9× 254 0.7× 266 0.8× 119 0.5× 54 1.4k
DJ Weisdorf United States 15 768 0.9× 390 0.9× 257 0.8× 157 0.5× 203 0.8× 19 1.4k
Robert Hast Sweden 23 1.4k 1.6× 345 0.8× 461 1.3× 587 1.7× 201 0.8× 99 2.0k

Countries citing papers authored by Hawk Kim

Since Specialization
Citations

This map shows the geographic impact of Hawk Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hawk Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hawk Kim more than expected).

Fields of papers citing papers by Hawk Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hawk Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hawk Kim. The network helps show where Hawk Kim may publish in the future.

Co-authorship network of co-authors of Hawk Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hawk Kim. A scholar is included among the top collaborators of Hawk Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hawk Kim. Hawk Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoo, Kwai Han, So Hyun Park, Hawk Kim, et al.. (2022). Low-dose abdominopelvic computed tomography in patients with lymphoma: An image quality and radiation dose reduction study. PLoS ONE. 17(8). e0272356–e0272356. 1 indexed citations
2.
Yoo, Kwai Han, Hyeoung‐Joon Kim, Yoo Hong Min, et al.. (2021). Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. PLoS ONE. 16(5). e0251011–e0251011. 6 indexed citations
3.
Uhm, Jieun, et al.. (2021). Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey. Blood Research. 56(1). 31–37. 2 indexed citations
4.
Park, Sungwoo, Eun‐Ji Choi, Hyewon Lee, et al.. (2021). Treatment-free remission of chronic myeloid leukemia in real-world practice by the detection limit of MR4.3. Leukemia Research. 105. 106578–106578. 1 indexed citations
5.
6.
Choi, Yunsuk, et al.. (2017). Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis. International Journal of Hematology. 106(4). 500–507. 3 indexed citations
7.
Heo, Sook‐Kyoung, Eui‐Kyu Noh, Jae‐Cheol Jo, et al.. (2016). LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells. PLoS ONE. 11(11). e0166589–e0166589. 19 indexed citations
8.
Lim, Ji‐Hun, Eul‐Ju Seo, Chan‐Jeoung Park, et al.. (2013). Cytogenetic classification in K orean multiple myeloma patients: prognostic significance of hyperdiploidy with 47–50 chromosomes and the number of structural abnormalities. European Journal Of Haematology. 92(4). 313–320. 13 indexed citations
9.
Lee, Je‐Hwan, Young‐Don Joo, Hawk Kim, et al.. (2012). Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine. Journal of Clinical Oncology. 31(6). 701–709. 77 indexed citations
10.
11.
12.
13.
Kim, Hee‐Jin, Hee Kyung Ahn, Chul Won Jung, et al.. (2012). KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Annals of Hematology. 92(2). 163–171. 49 indexed citations
14.
Kim, Hawk. (2011). Cancer Pain Management. The Korean Journal of Internal Medicine. 81(2). 185–189.
15.
Goh, Hyun‐Gyung, Soo-Young Choi, Ju‐Hee Bang, et al.. (2011). Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response4.5 (CMR4.5). Blood. 118(21). 2763–2763. 6 indexed citations
16.
Won, Young‐Woong, Jung Hye Kwon, Sung Yong Oh, et al.. (2011). Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL). Annals of Hematology. 91(2). 223–233. 10 indexed citations
17.
Kim, Seok Jin, Sung Yong Oh, Jin Seok Kim, et al.. (2010). Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma. Annals of Hematology. 90(5). 539–546. 23 indexed citations
18.
Kim, Seok Jin, Hyo Jin Lee, Hawk Kim, et al.. (2007). Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.. Blood. 110(11). 4843–4843.
19.
20.
Kim, Hawk, Jae-Hoo Park, Sung‐Jo Bang, et al.. (2005). A Phase II Study of Docetaxel and Cisplatin in Patients with Gastric Cancer Recurring After or Progressing During 5-FU/Platinum Treatment. Japanese Journal of Clinical Oncology. 35(12). 727–732. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yeo‐Kyeoung Kim Breakdown of academic impact, for papers by Yunsuk Choi Breakdown of academic impact, for papers by Hiroatsu Iida Breakdown of academic impact, for papers by Paul Shaughnessy Breakdown of academic impact, for papers by Karel Indrák Breakdown of academic impact, for papers by G. L. Phillips Breakdown of academic impact, for papers by M. J. Barnett Breakdown of academic impact, for papers by T. de Witte Breakdown of academic impact, for papers by DJ Weisdorf Breakdown of academic impact, for papers by Robert Hast
Rankless by CCL
2026